<DOC>
	<DOCNO>NCT00306839</DOCNO>
	<brief_summary>The purpose study evaluate mid long term postoperative pain disable complication open inguinal hernia repair Lichtenstein technique mesh fixation fibrin sealant ( FS ) , compare mesh fixation suture .</brief_summary>
	<brief_title>Efficacy Study Tissucol/Tisseel Fibrin Sealant Treat Inguinal Hernia</brief_title>
	<detailed_description>Subjects FS group operate Lichtenstein technique , mesh fixation fibrin sealant . Subjects control group operate conventional Lichtenstein technique ( mesh fixation suture ) . Hernia repair perform accord standardized Lichtenstein technique , technique tension free hernioplasty . A Polypropylene , heavyweight , macroporous mesh use ( 8x15 cm ) tailor individual patient requirement . The different way mesh fixation randomly assign within 24 hour operation . In FS group , two tail mesh fix together overlap edge surround cord . The edge join 1 suture . No suture use . First mesh put correctly place . A small spot ( 0.5ml ) FS apply pubis mesh without spray remain part ( 3,5ml ) mesh entire surface thin uniform layer spray . 2 ml Tissucol-Tisseel ( 4 ml fibrin sealant ) use per mesh . In control group , mesh fix conventional manner . Nerve resection ( occur ) record ; avoid .</detailed_description>
	<mesh_term>Hernia</mesh_term>
	<mesh_term>Hernia , Inguinal</mesh_term>
	<mesh_term>Fibrin Tissue Adhesive</mesh_term>
	<criteria>Signed informed consent obtain subject prior participation study Active male age 18 year 80 year Experiencing uncomplicated unilateral primary inguinal hernia experience uncomplicated bilateral hernia provide one hernia operate 12 month study followup Subjects eligible elective inguinal hernia repair use Lichtenstein technique . Recurrent , scrotal , incarcerated femoral hernia Hernia type L3 M3 accord EHS classification BMI equal 35 Concomitant abdominal surgery Ongoing long term analgesic steroid treatment Patients Clopidogrel Warfarin ( switch LMW subcutaneous heparin ) Known abuse alcohol drug Liver cirrhosis ( Child C ) Previous treatment Hypersensitivity bovine aprotinin Known immunodeficiency Severely compromised physical psychological health , investigator 's opinion affect patient compliance Concurrently participate another clinical trial receive another investigational drug device within last 30 day</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>Tissucol</keyword>
	<keyword>Tisseel</keyword>
	<keyword>Lichtenstein</keyword>
	<keyword>hernia</keyword>
	<keyword>inguinal</keyword>
</DOC>